CLINICAL UPDATES
 
Antiandrogens may increase mortality risk in men with CVD
Patients with CVD taking abiraterone or enzalutamide have a 43% higher risk of hospitalization, according to a recent study.
Read Dr. Badar Mian’s column
ADVERTISEMENT
 
Prostate-sparing treatment uses nanoparticles
An ultrafocal photothermal ablation technique appears safe and feasible for low/intermediate-risk localized prostate cancer.
Learn more

 
advertisement
Visit a Cysview® Reference Center in TX, OH, or CA
See hexaminolevulinate HCl in action in the operating room or clinic setting. Get answers and tips from an expert user. Travel and meal expenses are reimbursed. RSVP to discuss available dates and locations.

 
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
MORE FROM UROLOGY TIMES
 
Challenging case: Hematuria in man with a history of prostate Ca
Large study offers more evidence of ADT-Alzheimer’s link
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont